Receptor tyrosine kinases remain dormant until activated by ligand binding to the extracellular domain. Two mechanisms have been proposed for kinase activation: (i) ligand binding to the external domain of a receptor monomer may induce a conformational change that is transmitted across the cell membrane (intramolecular model) or (ii) the ligand may facilitate oligomerization, thereby allowing interactions between the juxtaposed kinase domains (intermolecular model). The receptor for colony-stimulating factor 1 was used to test these models. Large insertions at the junction between the external and transmembrane domains of the receptor, introduced by site-directed mutagenesis of the cDNA, were positioned to isolate the external domain and prevent transmembrane conformational propagation while allowing for receptor oligomerization. Such mutant receptors were expressed on the cell surface, bound ligand with high affinity, exhibited ligandstimulated autophosphorylation, and signaled mitogenesis and cellular proliferation in the presence of ligand. A second experimental strategy directly tested the intermolecular model of ligand activation. A hybrid receptor composed of the external domain of human glycophorin A and the transmembrane and cytoplasmic domains of the colony-stimulating factor 1 receptor exhibited anti-glycophorin antibody-induced kinase activity that supported mitogenesis. Our data strongly support a mechanism of receptor activation based on ligand-induced receptor oligomerization.
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Growth factor receptors such as those for insulin, epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and colony-stimulating factor 1 (CSF-1) are integral membrane glycoproteins sharing a number of common structural features, including an extracellular ligand-binding domain, a stretch of [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] hydrophobic amino acids presumed to span the membrane once, and a large intracellular domain with canonical sequences characteristic of an ATP catalytic site (1) . In the normal cell, activation of the enzymatic function results only from binding of the appropriate growth factor.
Recent studies have demonstrated dimer formation for the EGF (2) (3) (4) (5) and PDGF (6) (7) (8) receptors, although the causal relationship between receptor oligomerization and kinase activation in the intact cell has not been established. In addition, some observations suggest that kinase activation can occur in the absence of oligomerization (9) (10) (11) . Whatever the activation mechanism may be, ligand binding initiates a cascade of events beginning with receptor autophosphorylation and phosphorylation of intracellular substrates, culminating in DNA synthesis and cell division.
Two models can describe the mechanism of kinase activation by ligand binding: an intramolecular or an intermolecular process (2, 12) . In the simplest type of intramolecular model, a single receptor monomer constitutes a fully functional independent transducing unit, and ligand binding activates the kinase function by transmitting a conformational signal across the transmembrane domain. In the simplest type of intermolecular model, ligand binding facilitates oligomerization and, by allowing critical interactions such as transphosphorylation (13, 14) to occur between the juxtaposed cytoplasmic domains, results in kinase activation. We have directly tested these two models in intact cells using the CSF-1 receptor (CSF-1R), encoded by the protooncogene c-fms (15) . CSF-1R is a transmembrane protein of molecular weight ca. 160,000 expressed on cells of the monocyte/ macrophage lineage and on placental trophoblasts. Our results strongly support ligand-induced oligomerization as the mechanism for kinase activation in CSF-1R.
MATERIALS AND METHODS
cDNA Cloning and Plasmid Constructions. A 600-base-pair fragment derived from the 5' end of a partial murine CSF-1R cDNA clone (P. Browning, E. Feingold, A.W.L., and A.W.N., unpublished data) was used to screen a murine B-cell cDNA library (16) , yielding a single 3.7-kilobase clone. Sequencing established that this clone encoded only amino acids 17-977 of the published sequence (17) . A synthetic oligonucleotide was used to complete the coding region including the entire published signal peptide. Site-directed mutagenesis (Amersham kit) was used to create an Ava I site at nucleotide 1602 in M13mpl9 that converted GAT (Asp-509) to GAG (Glu). Oligonucleotides encoding the helix or polyglycine sequences were synthesized with Ava I ends, inserted into this site, and confirmed by DNA sequencing. To construct the hybrid receptor between human glycophorin A (GpA) and CSF-1R, a two-step polymerase chain reaction procedure (18) was utilized, the details of which are available upon request. The final plasmid contained the coding sequence for the entire external region of GpA (a 19-amino acid signal peptide and a 72-amino acid extracellular domain) and the transmembrane and cytoplasmic domains of CSF-1R, a total of 558 amino acids. To obtain an intact GpA cDNA necessary as a negative control, the codons for the missing carboxyl-terminal 5 amino acids (19) and mutant CSF-lRs were phosphorylated on serines alone in the basal state, and that phosphotyrosine appeared only with CSF-1 stimulation (data not shown).
Insertional Mutants Show CSF-1-Stimulated DNA Synthesis and Proliferation. Each measurement of [3H]thymidine incorporation (Fig. 3 Upper) was repeated at least once and for two independently selected 32D clones per construct. In the presence of CSF-1, parental 32D cells showed basal incorporation only, consistent with the absence of CSF-1R, although IL-3 in the same cells had a profound mitogenic effect. On the other hand, clones expressing either the wild-type or a mutant receptor responded to CSF-1 with an incorporation that was 75-90% of the IL-3-induced uptake, and could not be distinguished from each other. The findings of the methylcellulose proliferation assay are in agreement (Fig. 3 Lower). In the absence of growth factors (row A), the colonies 412 WT-1 Hx-l PG6-1 PG12-1 ±-+ --± -+t. Fig. 4 . With R4B15 (antiFms; Fig. 4A ), a specific band at 84 kDa was seen in both the -and + lanes. The predicted molecular mass after cleavage of the signal peptide is 60 kDa; the difference presumably comes from the addition of both O-linked (15 sites) and N-linked (1 site) oligosaccharides and is close to that estimated for GpA in K562 cells (33) . With 1G2 (Fig. 4B) , a band at the same molecular mass was more prominent in the + lane. A double immunoprecipitation was also performed (Fig.  4C) , with 1G2 (anti-phosphotyrosine) followed by R4B15 (anti-Fms), and demonstrated unequivocally that the tyrosine kinase function of the GpA-CSF-lR hybrid can be activated by crosslinking with anti-GpA antibodies.
Anti-GpA Antibodies Induce a Mitogenic Response in the GpA-CSF-1R Hybrid. A titration effect was seen with serial dilutions of the anti-GpA antiserum (Fig. SA) . At the highest concentration tested, [3H]thymidine uptake was almost 5 times the basal level, compared to an 8.6-fold induction with IL-3 in the same experiment. At 1:5000, induction was 75% over basal. At the same time, the anti-GpA antiserum had no effect on clone M, a 32D cell line expressing wild-type GpA only (Fig. SA) , or on the cell line expressing wild-type CSF-1R (data not shown). The titration curve was determined in three separate experiments and for a second independently selected M or BM clone, with similar results. The mitogenic effect is specific for the anti-GpA antibodies present in the antiserum since it was blocked by addition of purified GpA (Fig. SB) .
DISCUSSION
Our experiments were designed to address two specific questions. The first is whether CSF-1R transduces the ligandbinding signal by means of a conformational change propagated across the transmembrane region. The helix and polyglycine mutants contained insertions that were large (6, 12, and 14 amino acids) and heterogeneous in charge and secondary structural characteristics. To disrupt the intramolecular activation pathway, these insertions had been introduced at the junction between the extracellular ligand-binding and transmembrane domains of CSF-1R. Hydropathy plots predict only a single transmembrane domain in the tyrosine kinase receptors; both the external and the cytoplasmic domains of several receptors have been synthesized in soluble form by recombinant DNA techniques (34) (35) (36) , thus excluding the existence of other significant membrane binding regions. In the presence of these insertions, ligandinduced conformational changes are unlikely to be transmitted to the transmembrane domain, since, in the case of the helix insertion, the energy cost of perturbing a thermodynamically stable a-helix would be prohibitive, and in the case of the polyglycine insertions, the flexible internal coordinates would serve as an efficient shock absorber at little energy cost. Our results show that both types of mutants are able to function normally, exhibiting CSF-1-induced kinase activation followed by DNA synthesis and cell division. This indicates that signal transduction in CSF-1R is not critically dependent on the precise nature of the link between the external and transmembrane domains. It is unlikely that our insertions were ineffective in blocking the transmission of ligand-induced conformational changes, in view of the many examples where small insertions, deletions, or even single amino acid substitutions can exert a detrimental effect if introduced at critical regions. For example, many single amino acid substitutions at the a1/,32 interface in hemoglobin drastically reduce cooperativity (37) , and in the EGF receptor an insertion of 4 amino acids in the kinase domain renders it biologically inactive (38) .
The second question we addressed is the possibility that juxtaposition of the kinase domains is a sufficient trigger for activation. To this end, we constructed a hybrid where the external domain of CSF-1R was replaced by the 72-amino acid external domain of GpA, the major sialoglycoprotein from the human erythrocyte membrane. GpA is a prototypic type I membrane glycoprotein but bears no relation to receptor tyrosine kinases. It appears to be a structural protein in red cells with no role in signal transduction; anti-GpA antibodies have no known effect on red-cell function (39, 40 
